Diermeier-Daucher S - Search Results

1

Cell type specific applicability of 5-ethynyl-2'-deoxyuridine (EdU) for dynamic proliferation assessment in flow cytometry.

Diermeier-Daucher S, Clarke ST, Hill D, Vollmann-Zwerenz A, Bradford JA, Brockhoff G. Diermeier-Daucher S, et al. Cytometry A. 2009 Jun;75(6):535-46. doi: 10.1002/cyto.a.20712. Cytometry A. 2009. PMID: 19235202 Free article.

2

Multichromatic phenotyping of HER receptor coexpression in breast tumor tissue samples using flow cytometry--possibilities and limitations.

Vollmann-Zwerenz A, Diermeier-Daucher S, Wege AK, Sassen A, Schmidt-Brücken E, Hofstaedter F, Ortmann O, Nauwelaers F, Brockhoff G. Vollmann-Zwerenz A, et al. Among authors: diermeier daucher s. Cytometry A. 2010 Apr;77(4):387-98. doi: 10.1002/cyto.a.20868. Cytometry A. 2010. PMID: 20151455 Free article.

3

Dynamic proliferation assessment in flow cytometry.

Diermeier-Daucher S, Brockhoff G. Diermeier-Daucher S, et al. Curr Protoc Cell Biol. 2010 Sep;Chapter 8:Unit 8.6.1-23. doi: 10.1002/0471143030.cb0806s48. Curr Protoc Cell Biol. 2010. PMID: 20853345

4

Modular anti-EGFR and anti-Her2 targeting of SK-BR-3 and BT474 breast cancer cell lines in the presence of ErbB receptor-specific growth factors.

Diermeier-Daucher S, Breindl S, Buchholz S, Ortmann O, Brockhoff G. Diermeier-Daucher S, et al. Cytometry A. 2011 Sep;79(9):684-93. doi: 10.1002/cyto.a.21107. Epub 2011 Jul 22. Cytometry A. 2011. PMID: 21786419 Free article.

5

Flow cytometric FRET analysis of erbB receptor interaction on a cell-by-cell basis.

Diermeier-Daucher S, Hasmann M, Brockhoff G. Diermeier-Daucher S, et al. Ann N Y Acad Sci. 2008;1130:280-6. doi: 10.1196/annals.1430.003. Ann N Y Acad Sci. 2008. PMID: 18596360

6

Flow cytometric FRET analysis of ErbB receptor tyrosine kinase interaction.

Diermeier-Daucher S, Brockhoff G. Diermeier-Daucher S, et al. Curr Protoc Cytom. 2008 Jul;Chapter 12:Unit12.14. doi: 10.1002/0471142956.cy1214s45. Curr Protoc Cytom. 2008. PMID: 18770646

7

Trifunctional antibody ertumaxomab: Non-immunological effects on Her2 receptor activity and downstream signaling.

Diermeier-Daucher S, Ortmann O, Buchholz S, Brockhoff G. Diermeier-Daucher S, et al. MAbs. 2012 Sep-Oct;4(5):614-22. doi: 10.4161/mabs.21003. Epub 2012 Jul 23. MAbs. 2012. PMID: 22820509 Free PMC article.

8

Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles.

Plander M, Seegers S, Ugocsai P, Diermeier-Daucher S, Iványi J, Schmitz G, Hofstädter F, Schwarz S, Orsó E, Knüchel R, Brockhoff G. Plander M, et al. Among authors: diermeier daucher s. Leukemia. 2009 Nov;23(11):2118-28. doi: 10.1038/leu.2009.145. Epub 2009 Aug 6. Leukemia. 2009. PMID: 19657365 Free article.

9

Presence of HER4 associates with increased sensitivity to Herceptin in patients with metastatic breast cancer.

Sassen A, Diermeier-Daucher S, Sieben M, Ortmann O, Hofstaedter F, Schwarz S, Brockhoff G. Sassen A, et al. Among authors: diermeier daucher s. Breast Cancer Res. 2009;11(4):R50. doi: 10.1186/bcr2339. Epub 2009 Jul 22. Breast Cancer Res. 2009. PMID: 19624808 Free PMC article.

10

HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women.

Wege AK, Chittka D, Buchholz S, Klinkhammer-Schalke M, Diermeier-Daucher S, Zeman F, Ortmann O, Brockhoff G. Wege AK, et al. Among authors: diermeier daucher s. Breast Cancer Res. 2018 Nov 20;20(1):139. doi: 10.1186/s13058-018-1072-1. Breast Cancer Res. 2018. PMID: 30458882 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page